Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis with <i>Pseudomonas aeruginosa</i>

Abstract

Nebulized MP-376was well tolerated and demonstrated significant clinical efficacy in heavily treated patients with CF with PA lung infection. Clinical trial registered with www.clinicaltrials.gov (NCT00677365).